Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · October 30, 2022

Dermatology Evaluation for Cutaneous Immune-Related AEs Is Associated With Improved Survival in Patients With Cancer Treated With Checkpoint Inhibition

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Dermatology evaluation for cutaneous immune related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
J Am Acad Dermatol 2022 Sep 13;[EPub Ahead of Print], TV Jacoby, N Shah, MS Asdourian, LL Thompson, TS Otto, NR LeBoeuf, Y Semenov, E Christopher Dee, KL Reynolds, ST Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading